ArticleJournal of cell science2026
Regulation of Leishmania surface coat proteins by the nuclear protein ESB1.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Unicellular Leishmania parasites cause leishmaniases and require a life cycle stage-specific surface coat for pathogenesis. A major protein component of this coat is δ-amastins, which are human infective amastigote life cycle stage-specific transmembrane glycoproteins. Leishmania genes are encoded in co-transcribed gene arrays with little gene-specific transcriptional control. Here, we show that the Leishmania mexicana ortholog of ESB1 (denoted LmxESB1), a nuclear protein we previously identified in the related parasite Trypanosoma brucei, is required for δ-amastin regulation. LmxESB1 localises to a promastigote-specific nuclear body and its deletion caused derepression of δ-amastin expression from specific chromosomal loci. This upregulated δ-amastin phenotype was unstable, recovering over time. Transcriptomic analysis of recovered mutants identified two additional factors - LmxM.34.0190, an NIF-like phosphatase NIFP1, and LmxM.23.0730, the RNA-binding protein RBP10 - where deletion of which also resulted in δ-amastin misexpression. We have therefore identified a novel Leishmania nuclear protein that contributes to δ-amastin repression in promastigotes and factors that act in parallel with LmxESB1. This expands our understanding of how Leishmania controls stage-specific gene expression of surface coat proteins necessary for pathogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.